Clinique Ovo
37
1
1
25
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
27.0%
10 terminated/withdrawn out of 37 trials
71.4%
-15.1% vs industry average
16%
6 trials in Phase 3/4
0%
0 of 25 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (37)
Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin
Role: lead
Identifying Candidates for Limited Dissection at Microdissection TESE.
Role: lead
Paternal Age and Fetal Aneuploidy
Role: lead
ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)
Role: lead
Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
Role: lead
Rescue Progesterone Supplementation During Frozen Embryo Transfer
Role: lead
Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin
Role: lead
Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
Role: lead
Timing of Oocyte Retrieval and Micro Testicular Sperm Extraction
Role: lead
Second Ovulation Induction
Role: lead
Menopur And Rekovelle Combination Study Version 2.0
Role: lead
DFI and Aneuploidies
Role: lead
Ovulation Triggering 2 vs 3 Follicles
Role: lead
Uterine Scratching in Intra-Uterine Insemination
Role: lead
Artificial Oocyte Activation
Role: lead
Correlation of Oxidative Stress and Oocyte Quality in Fertility Preservation
Role: lead
Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)
Role: lead
Personalizing Window of Implantation During Frozen Embryo Transfer
Role: lead
The Paternal Clock: Uncovering the Consequences of Advanced Paternal Age on Sperm DNA Fragmentation
Role: lead
Modified Rekovelle and Menopur Combination Protocol to Avoid Monitoring Before Day 10 of Stimulation
Role: lead